Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person negative regulation of programmed necrotic cell death
| Class:Id | GO_BiologicalProcess:9637490 |
|---|---|
| _displayName | negative regulation of programmed necrotic cell death |
| _timestamp | 2019-02-17 03:59:54 |
| accession | 0062099 |
| created | [InstanceEdit:9637466] Weiser, JD |
| definition | Any process that decreases the frequency, rate or extent of programmed necrotic cell death. |
| modified | [InstanceEdit:9658105] Weiser, JD, 2019-08-09 [InstanceEdit:9666277] Weiser, JD, 2019-11-04 [InstanceEdit:9676538] Cook, Justin, 2020-02-17 |
| name | negative regulation of programmed necrotic cell death |
| referenceDatabase | [ReferenceDatabase:1] GO |
| (goBiologicalProcess) | [Reaction:9693978] Small molecule inhibitor binds RIPK1, RIPK3 [Homo sapiens] [Reaction:9693980] Dabrafenib binds RIPK3 [Homo sapiens] [NegativeRegulation:9693342] Negative regulation by 'dithiocarb-C191-GSDMD(1-275) [cytosol]' [NegativeRegulation:9716201] Negative regulation by 'S-(2-succinyl)-C191-GSDMD [cytosol]' |
| [Change default viewing format] | |
No pathways have been reviewed or authored by negative regulation of programmed necrotic cell death (9637490)
